Best Neuroscience Journals (2026): Ranked by Fit and Impact
A ranked guide to the top 12 neuroscience journals by scope fit, selectivity, APC, and review time, spanning molecular, systems, and clinical neuroscience.
Readiness scan
Which neuroscience journal fits your draft?
Run the Free Readiness Scan with your draft to see fit, framing, and desk-reject risk against the leading neuroscience venues.
Quick answer: The best neuroscience journals depend on manuscript type: Nature Neuroscience and Neuron are the strongest original-research targets for broad mechanistic neuroscience; Brain and Annals of Neurology lead for clinical neurology; Journal of Neuroscience remains a respected broad-society venue; and NeuroImage is strongest when the contribution is imaging-first rather than mechanism-first. Use 2025 JIFs from the 2026 JCR release as a ceiling check, but choose by mechanism depth, disease relevance, imaging or computational emphasis, and the reviewers most likely to understand the paper.
Here's the ranked breakdown with practical guidance on what each journal actually publishes and who should submit there.
If your search is metric-only, use the 2026 JIF lookup guide for the current lookup workflow or the dedicated Nature Neuroscience metrics page for Nature Neuroscience. This page is a journal-choice shortlist, so it uses metrics only as one input alongside scope, audience, review model, and manuscript type.
Before picking from the neuroscience journals below, run a neuroscience manuscript fit check to see whether your draft is closer to a top-tier or accessible-tier target before you commit to a submission.
Which neuroscience journals are elite tier?
These journals publish discoveries that change how neuroscientists understand the brain. New circuits, new cell types, new disease mechanisms, and field-changing techniques belong here.
Which top neuroscience journals rank highest for submission fit?
Rank | Journal | Citation tier |
|---|---|---|
1 | Nature Neuroscience | Elite primary-research flagship |
2 | Neuron | Elite Cell Press neuroscience |
3 | Nature Reviews Neuroscience | Invited review flagship, not an original-research target |
4 | Molecular Psychiatry | Strong psychiatry-neuroscience bridge |
5 | Brain | Leading clinical-neuroscience venue |
6 | Annals of Neurology | Strong clinical and translational neurology |
7 | eLife (Neuroscience section) | Open-review neuroscience option |
8 | Journal of Neuroscience | Broad society journal with strong field recognition |
- Nature Neuroscience for broad causal or systems-neuroscience mechanisms.
- Neuron for larger Cell Press-style mechanistic, cellular, circuit, or computational stories.
- Brain for clinical neurology, disease mechanism, and patient-relevant neuroscience.
- Journal of Neuroscience for broad SfN-community reach when the paper is rigorous but not flagship-level.
- NeuroImage for imaging-first methods, datasets, and brain-mapping applications.
Readiness check
Find out what this manuscript actually needs before you choose a service.
Run the free scan to see whether the issue is scientific readiness, journal fit, or citation support before paying for more help.
How do neuroscience journals compare by manuscript type?
Manuscript type | Best first target | Strong backup | Avoid if |
|---|---|---|---|
Broad mechanistic neuroscience | Nature Neuroscience | Neuron | The paper needs a specialist audience to understand why it matters |
Large molecular, cellular, or circuit story | Neuron | Cell Reports or Current Biology | The manuscript has one narrow observation without mechanistic closure |
Clinical neurology or disease mechanism | Brain | Annals of Neurology | The paper is mainly basic biology without patient or disease relevance |
Society-wide neuroscience audience | Journal of Neuroscience | eNeuro or specialized society journal | The paper needs prestige signaling more than community reach |
Neuroimaging method or application | NeuroImage | Imaging Neuroscience or Cerebral Cortex | The core claim is not imaging-driven |
Invited synthesis or field model | Nature Reviews Neuroscience | Trends in Neurosciences | The manuscript is unsolicited original research |
What are the current metric signals for top neuroscience journals?
Metric-source note: JIF rows below use 2025 JIF data from the 2026 JCR release. This shortlist is not the metric owner for exact single-journal searches; use the dedicated metric pages for Nature Neuroscience, Neuron, Brain, and Journal of Neuroscience.
Journal | Impact Factor (2025 JIF / 2026 JCR) | Scope / metric posture | Best for |
|---|---|---|---|
Nature Neuroscience | 20.3 | Elite specialist neuroscience | Strong ceiling signal only if the paper changes a mechanistic or systems-neuroscience principle |
Neuron | 16.9 | Elite Cell Press neuroscience | Strong fit when the story needs more mechanistic depth or figure space than a short-format flagship |
Brain | 12.6 | Flagship clinical neurology | Strong target only when neurological consequence, patient relevance, or disease mechanism is central |
Journal of Neuroscience | 4.3 | Broad society neuroscience | Lower current JIF, but high field recognition when breadth and SfN audience matter more than prestige signaling |
When should you choose Nature Neuroscience?
Nature Neuroscience is the leading specialty original-research journal in the field. It publishes across all areas of neuroscience, from molecular and cellular to systems and cognitive, with a preference for studies that reveal new principles of brain function. The journal wants complete, multi-technique stories with both mechanistic depth and functional relevance.
Acceptance rate: ~7-8%. APC: hybrid OA option. Review time: 9-day median first editorial decision, longer after external review. Scope: all neuroscience, mechanistic focus, multi-technique studies.
When should you choose Neuron?
Neuron (Cell Press) is Nature Neuroscience's primary competitor. The journal publishes molecular, cellular, systems, and computational neuroscience, with particular strength in circuit neuroscience and synaptic biology. Neuron tends to publish larger papers than Nature Neuroscience, with more experimental depth. If your story requires 8-10 figures to tell properly, Neuron's format accommodates that.
Acceptance rate: ~8%. APC: None (hybrid OA). Review time: 6-10 weeks. Scope: Molecular to systems neuroscience, circuits, synaptic biology, neural coding.
When should you choose Nature Reviews Neuroscience?
Nature Reviews Neuroscience publishes invited reviews and perspectives. It's not a submission target for original research, but the IF is high because neuroscience reviews are heavily cited. Understanding what's published here helps you identify hot topics.
Which neuroscience journals sit in the strong tier?
These journals publish strong neuroscience that advances understanding without necessarily redefining a subfield. Important findings in established areas, new techniques, and translational insights find homes here.
When should you choose Molecular Psychiatry?
Molecular Psychiatry bridges neuroscience and psychiatry, publishing research on the biological basis of psychiatric disorders. If your neuroscience paper connects to depression, schizophrenia, anxiety, addiction, or autism, Molecular Psychiatry is an excellent fit. The journal values both animal model studies and human neuroimaging or genetics data.
Acceptance rate: ~10%. APC: None (hybrid OA). Review time: 6-10 weeks. Scope: Psychiatric neuroscience, neurogenetics, neuroimaging of psychiatric disorders, psychopharmacology.
When should you choose Brain?
Brain is the top journal for clinical neuroscience and neurology research. It publishes studies on neurological diseases (Alzheimer's, Parkinson's, epilepsy, stroke, MS) with emphasis on understanding pathophysiology and improving diagnosis. If your paper involves patient data, clinical imaging, or translational work relevant to neurological disease, Brain is the first target.
Acceptance rate: ~12-15%. APC: None (hybrid OA). Review time: 4-8 weeks. Scope: Clinical neuroscience, neurological disease, neuroimaging, neuropathology.
When should you choose Annals of Neurology?
Annals of Neurology is the journal of the American Neurological Association. It publishes clinical and translational neuroscience, with a strong tradition in movement disorders, dementia, and cerebrovascular disease. The journal is slightly more clinically oriented than Brain and accepts clinical trial results alongside mechanistic studies.
Acceptance rate: ~12%. APC: None (hybrid OA). Review time: 4-8 weeks. Scope: Clinical neuroscience, neurological trials, translational neurology.
When should you choose eLife's neuroscience section?
ELife publishes across all biology, but its neuroscience section is one of the strongest. The journal's open peer review model means reviews are published alongside the paper, which promotes transparency. eLife is particularly receptive to systems neuroscience, computational approaches, and innovative methodology.
Acceptance rate: ~15%. APC: $2,000. Review time: 6-10 weeks. Scope: All neuroscience, open access, computational and systems neuroscience.
Which neuroscience journals are more accessible but still reputable?
These journals publish solid neuroscience that contributes to the field without requiring field-defining results. Focused studies, methodological contributions, and research in specialized areas find appropriate audiences here.
When should you choose Journal of Neuroscience?
The Journal of Neuroscience (JNeurosci) is the flagship journal of the Society for Neuroscience (SfN). Despite a moderate IF, JNeurosci is the most widely read neuroscience journal by volume and has a massive readership through SfN membership. The journal publishes across all areas of neuroscience and is known for rigorous peer review.
Don't let the IF fool you. A JNeurosci paper reaches tens of thousands of neuroscientists through the SfN community, and hiring committees in neuroscience know the journal's reputation is stronger than its IF suggests.
Acceptance rate: ~20-25%. APC: None (hybrid OA). Review time: 4-8 weeks. Scope: All neuroscience, both basic and translational.
When should you choose Cerebral Cortex?
Cerebral Cortex focuses on the structure and function of the cerebral cortex, including neuroimaging, cortical circuits, and cognitive neuroscience. If your paper involves cortical organization, fMRI studies, or cortical electrophysiology, this is a well-matched specialty venue.
Acceptance rate: ~20%. APC: None (hybrid OA). Review time: 4-8 weeks. Scope: Cortical function, neuroimaging, cognitive neuroscience.
When should you choose Neuroscience?
Neuroscience (IBRO journal, published by Elsevier) covers all areas of neuroscience research. It's a broad-scope, accessible journal that accepts technically sound work across the field. The acceptance rate is reasonable, and the journal has a long history in the neuroscience community.
Acceptance rate: ~30%. APC: None (hybrid OA). Review time: 4-8 weeks. Scope: All neuroscience, basic research focus.
When should you choose Frontiers in Neuroscience?
Frontiers in Neuroscience is a large open-access journal covering all neuroscience subfields. It provides fast turnaround and open-access visibility. The journal is divided into specialty sections (Neurodegeneration, Neural Circuits, etc.), which helps match your paper to appropriate reviewers.
Acceptance rate: ~35-40%. APC: $2,950. Review time: 3-6 weeks. Scope: All neuroscience, open access, section-based organization.
When should you choose NeuroImage?
NeuroImage is the top journal specifically for neuroimaging methods and applications. If your paper's primary contribution is imaging-based (fMRI, PET, EEG/MEG, diffusion MRI), NeuroImage's specialized readership will evaluate it more fairly than a general neuroscience journal.
Acceptance rate: ~20%. APC: None (hybrid OA). Review time: 4-8 weeks. Scope: Neuroimaging methods, brain mapping, computational neuroimaging.
Decision framework
If your paper reveals a new neural circuit, cell type, or synaptic mechanism, start with Nature Neuroscience or Neuron. These journals publish the discoveries that textbooks eventually incorporate.
If your paper is about neurological disease, Brain or Annals of Neurology are the top clinical neuroscience venues. For psychiatric disorders, Molecular Psychiatry is the best fit.
If your paper is a systems neuroscience or computational study, Neuron, eLife, or JNeurosci are strong options. eLife is particularly receptive to computational approaches.
If your paper is primarily neuroimaging, NeuroImage is the specialty home. Cerebral Cortex works well for cortical imaging studies with a cognitive angle.
If your paper is basic neuroscience without a disease connection, Journal of Neuroscience is the workhorse journal. Its IF understates its influence in the field.
If you need fast open-access publication, Frontiers in Neuroscience provides the quickest path. eLife is a higher-prestige OA option.
Common mistakes neuroscience researchers make when choosing journals
Chasing IF at the expense of audience fit. A study on cerebellar motor learning might get published in a high-IF general journal, but it will get more reads and citations in a journal where cerebellar researchers actually look. Audience matters more than IF for career impact in neuroscience.
Submitting clinical data to basic science journals. Nature Neuroscience and Neuron want mechanisms. If your paper reports neuroimaging findings in patients without explaining the underlying biology, Brain or Annals of Neurology will evaluate it more fairly.
Ignoring Journal of Neuroscience. JNeurosci's IF (~4) looks modest, but SfN has over 35,000 members who read the journal. In hiring committees and grant reviews, JNeurosci papers carry weight that the IF alone doesn't capture.
Not considering methods journals. If your paper's main contribution is a new technique (optogenetics variant, imaging method, analysis pipeline), consider Nature Methods or NeuroImage rather than a findings-focused journal. Methods papers have different evaluation criteria.
Submitting too-long papers to short-format journals. Nature Neuroscience expects concise papers (4-6 figures). Neuron allows longer stories (8-10 figures). Matching your paper's natural length to the journal's format prevents frustrating revision requests.
In our pre-submission review work on neuroscience journals
Across neuroscience manuscripts, three patterns generate the most consistent journal-selection failures. These are not rank-table problems. They show up in the abstract, first figure, Methods, controls, and cover letter before the journal choice is even defensible.
Mechanism-first papers sent to audience-first journals. We see cellular and circuit neuroscience manuscripts where the experiments are strong, but the manuscript is sent to a clinical or translational journal because the disease context feels attractive. Editors at Brain or Annals of Neurology need patient relevance, diagnostic implications, or disease-pathophysiology logic. A synaptic mechanism paper with a disease paragraph belongs first in Neuron, Nature Neuroscience, Journal of Neuroscience, or a specialist cellular neuroscience journal. The audit point is usually visible in the title, first figure, and cover letter: if the central claim is a molecular or circuit mechanism, do not ask a clinical journal to care because the Discussion mentions disease.
Check whether your mechanism claim supports the target journal ->
Neuroimaging papers judged by the wrong novelty standard. Imaging papers often fail at broad neuroscience journals because the claimed biological insight is thinner than the imaging method. In practice, NeuroImage or a cognitive-neuroscience venue can be the better commercial and citation decision if the pipeline, cohort, or analysis method is the durable contribution. Chasing Nature Neuroscience for an imaging paper without a clear mechanistic finding often burns months without improving the final publication. The practical test is whether the abstract names a neuroscience mechanism or mainly names a dataset, preprocessing choice, classifier, or imaging contrast. If the durable contribution is the imaging protocol or analysis pipeline, the ranking table should not push the manuscript toward Nature Neuroscience.
Check whether your imaging paper has the right venue frame ->
Review journals placed in the wrong list. Nature Reviews Neuroscience has a very high citation profile, but it is not a normal original-research target. Treating it as a rank-one target for an original manuscript confuses the searcher and the submission plan. For an original research paper, Nature Neuroscience, Neuron, Brain, Journal of Neuroscience, NeuroImage, or a field-specific journal are the practical options. In the manuscript package, this distinction changes the whole strategy: an invited-review venue needs a proposed synthesis and author authority, while an original-research venue needs results, controls, statistical analysis, data availability, and a clear figure sequence.
Check whether your target ladder starts with reader fit ->
The check we use is simple: name the manuscript's durable contribution before choosing the journal. If the durable contribution is a causal mechanism with broad field consequence, Nature Neuroscience or Neuron is plausible. If it is patient stratification, Brain or Annals of Neurology may be cleaner. If it is an imaging dataset, NeuroImage may beat a higher-prestige title. If it is a society-audience paper with rigorous but narrower scope, Journal of Neuroscience can be the better target.
This guide tells you what neuroscience editors look for by venue type; the review tells you whether YOUR paper passes the abstract, figures, methods, statistics, and cover letter checks for that target. Paid Manusights reviews include a 60-day money-back guarantee, and we do not train models on submitted manuscripts.
Submit If
Submit to a higher-tier neuroscience journal if:
- the abstract can name the mechanism, circuit, clinical implication, or imaging contribution without relying on prestige language
- the first two figures prove why the claim matters beyond one narrow model, cohort, region, or assay
- the methods, statistics, data availability, and limitation language match the target journal's reviewer pool
Think Twice If
- The abstract and first two figures are mechanism-light but disease-heavy. A clinical or translational frame does not make a basic neuroscience result fit Brain or Annals of Neurology unless the patient relevance is real in the data.
- The methods section and main table describe an imaging pipeline more than a biological claim. NeuroImage, Cerebral Cortex, or a cognitive-neuroscience venue may be cleaner than a broad mechanistic journal if the biology is secondary to the method.
- The target is chosen from the JIF column alone. Nature Neuroscience, Neuron, Brain, Journal of Neuroscience, and NeuroImage reward different evidence packages; a higher JIF does not repair a weak audience match.
How to use this list
Impact factor is one signal, not the whole picture. The journals ranked above vary in scope, editorial culture, and what they consider a strong submission. The right journal for your paper depends on how your study sits within the field's research agenda, not just on which title has the highest number next to it.
A paper with solid methodology and honest conclusions that doesn't quite reach the novelty bar of the top-ranked journals will fare better at the second or third tier than a round of rejections from journals above its weight class. Start with an honest assessment of where your work sits, not where you wish it sat.
Before targeting any journal on this list, verify the current author guidelines directly. Word limits, submission system requirements, and scope boundaries change. The rankings above reflect current editorial positioning and recent metric tiers, but exact JIF lookup belongs on the individual metric pages.
Get your manuscript ready
Before submitting to any neuroscience journal, run your manuscript through a manuscript readiness and scope check to check formatting, statistical reporting, and figure quality. Neuroscience papers with multi-panel electrophysiology or imaging figures are especially prone to labeling errors and statistical inconsistencies that trigger reviewer concerns.
How to choose from this list
- Match scope precisely. A neuroscience paper on clinical outcomes fits different journals than one on mechanisms.
- Check your constraints. Funder OA mandates, APC budgets, and timeline requirements all narrow the list.
- Prioritize your audience. The best journal is where researchers who should cite your work actually read.
- Be realistic about selectivity. If acceptance is <10%, have your backup journal identified before submitting.
Last verified: June 30, 2026 against current Nature Portfolio metrics for Nature Neuroscience, JCR-release context, SCImago, official journal pages, and Manusights neuroscience submission-fit review patterns. Check JCR directly for exact rank tables, as annual updates shift rankings.
How this page was created
This page was created from Clarivate JCR-release context, SCImago neuroscience rankings, official scope pages from Nature Neuroscience, Neuron, Brain, Journal of Neuroscience, and our pre-submission review work on neuroscience submission fit. In that work, the recurring mistake is choosing by prestige tier before deciding whether the manuscript is causal-neuroscience, clinical-neurology, imaging-method, or broad-society work.
Frequently asked questions
For original research, the strongest broad choices are Nature Neuroscience for causal, concept-shifting neuroscience, Neuron for comprehensive molecular-to-systems work, and Brain for clinical neurology. Use the dedicated metrics page for exact current JIF context.
In neuroscience, a JIF above 15 is elite, 7-15 is strong, and 3-7 can still represent respected specialist journals. Use this list for journal choice, not metric lookup alone.
Yes. eLife, Nature Communications, PLOS Biology, Frontiers in Neuroscience, and other open-access or hybrid journals can be reputable when the scope, publisher, indexing, and review model fit the manuscript.
No. Use JIF as a ceiling check, then choose by manuscript type, mechanism depth, clinical relevance, imaging or computational emphasis, audience, review model, and whether the journal regularly publishes your kind of neuroscience claim.
Sources
Final step
Run the scan before you spend more on editing or external review.
Use the Free Readiness Scan to get a manuscript-specific signal on readiness, fit, figures, and citation risk before choosing the next paid service.
Best for commercial comparison pages where the buyer is still choosing the right help.
Anthropic Privacy Partner. Your manuscript is never used to train any model.